Literature DB >> 15683426

Decreased numbers and impaired function of circulating dendritic cell subsets in patients with chronic hepatitis B infection (R2).

Xue-Zhang Duan1, Hui Zhuang, Min Wang, Han-Wei Li, Jing-Chao Liu, Fu-Sheng Wang.   

Abstract

BACKGROUND AND AIM: To investigate the frequencies, numbers and function of circulating dendritic cell (DC) subsets in patients with hepatitis B virus (HBV) infection, we assayed the circulating precursor DC subsets (including pDC1 and pDC2) and their ability in patients at various stages of HBV infection in vitro.
METHODS: Circulating pDC1 and pDC2 frequencies in peripheral blood mononuclear cells (PBMC) were analyzed by flow cytometric analysis. Costimulatory molecule expression and allostimulatory mixed lymphocyte reaction (AMLR) of DC1, cultured from PBMC in vitro, were detected in patients with chronic hepatitis B (CHB). On behalf of pDC2, interferon (IFN)-alpha production of PBMC was determined by the ELISA method in HBV-infected patients.
RESULTS: The number of circulating pDC1 decreased only in patients with liver cirrhosis (LC) compared with that in normal controls. However, pDC2 numbers decreased in both CHB and LC patients. DC1 from CHB patients showed lower expression of costimulatory molecules CD80, CD86 and impaired allostimulatory mixed lymphocyte reaction (AMLR) compared with those in normal controls. The ability of PBMC to secrete IFN-alpha also decreased significantly in patients with chronic HBV infection.
CONCLUSIONS: Our results suggest that patients with chronic HBV infection have a significantly lower expression of costimulatory molecules and impaired AMLR of pDC1, as well as decreased number and impaired function of circulating pDC2, which may be partially related to HBV disease progression in these patients. (c) 2004 Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15683426     DOI: 10.1111/j.1440-1746.2004.03529.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  21 in total

1.  Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro.

Authors:  M Shi; S Qian; W-W Chen; H Zhang; B Zhang; Z-R Tang; Z Zhang; F-S Wang
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

2.  Restoration of TLR3-activated myeloid dendritic cell activity leads to improved natural killer cell function in chronic hepatitis B virus infection.

Authors:  Eric T T L Tjwa; Gertine W van Oord; Paula J Biesta; Andre Boonstra; Harry L A Janssen; Andrea M Woltman
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

Review 3.  The role of innate immunity in HBV infection.

Authors:  Qiuju Han; Cai Zhang; Jian Zhang; Zhigang Tian
Journal:  Semin Immunopathol       Date:  2012-07-20       Impact factor: 9.623

Review 4.  Plasmacytoid dendritic cells in antiviral immunity and autoimmunity.

Authors:  Fei Tang; Qiumei Du; Yong-Jun Liu
Journal:  Sci China Life Sci       Date:  2010-03-07       Impact factor: 6.038

5.  Downregulation of TLR7/9 leads to deficient production of IFN-α from plasmacytoid dendritic cells in chronic hepatitis B.

Authors:  Ning Xu; Hang-Ping Yao; Guo-Cai Lv; Zhi Chen
Journal:  Inflamm Res       Date:  2012-06-10       Impact factor: 4.575

6.  Functional impairment of human myeloid dendritic cells during Schistosoma haematobium infection.

Authors:  Bart Everts; Ayola A Adegnika; Yvonne C M Kruize; Hermelijn H Smits; Peter G Kremsner; Maria Yazdanbakhsh
Journal:  PLoS Negl Trop Dis       Date:  2010-04-20

7.  Impairment of monocyte-derived dendritic cells in idiopathic pulmonary arterial hypertension.

Authors:  Weiyan Wang; Hui Yan; Weiguo Zhu; Yu Cui; Junzhu Chen; Xingxiang Wang; Shan Li; Jianhua Zhu
Journal:  J Clin Immunol       Date:  2009-08-20       Impact factor: 8.317

8.  Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus.

Authors:  Marjoleine L Op den Brouw; Rekha S Binda; Mark H van Roosmalen; Ulrike Protzer; Harry L A Janssen; Renate G van der Molen; Andrea M Woltman
Journal:  Immunology       Date:  2008-06-28       Impact factor: 7.397

9.  Hepatitis B core antigen upregulates B7-H1 on dendritic cells by activating the AKT/ERK/P38 pathway: a possible mechanism of hepatitis B virus persistence.

Authors:  Man Li; Zhen-Hua Zhou; Xue-Hua Sun; Xin Zhang; Xiao-Jun Zhu; Shu-Gen Jin; Ya-Ting Gao; Yun Jiang; Yue-Qiu Gao
Journal:  Lab Invest       Date:  2016-09-12       Impact factor: 5.662

10.  Peripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis B virus (HBV) infection.

Authors:  S Tavakoli; I Mederacke; S Herzog-Hauff; D Glebe; S Grün; D Strand; S Urban; A Gehring; P R Galle; W O Böcher
Journal:  Clin Exp Immunol       Date:  2007-11-20       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.